« Previous AbstractDetecting lung infections in breathprints: empty promise or next generation diagnosis of infections    Next AbstractChemical identification and quantification of volatile organic compounds emitted by sewage sludge »

Expert Rev Respir Med

Title:		Lung cancer breath tests
Author(s):		Haick H; Hashoul D;
Address:		"a Department of Chemical Engineering and Russell Berrie Nanotechnology Institute , Technion- Israel Institute of Technology , Haifa , Israel"
Journal Title:		Expert Rev Respir Med
Year:		2019
Volume:		20190508
Issue:		7
Page Number:		597 - 599
DOI:		10.1080/17476348.2019.1614918
ISSN/ISBN:		1747-6356 (Electronic) 1747-6348 (Linking)
Abstract:		"The current letter describes the rational behind breath analysis of lung cancer and the progress made so far by means of mass spectrometry and smart sensor arrays. Additionally, it presents and discusses the potential of breath analysis in enabling inexpensive and non-invasive technology that would allow efficient early detection of cancer; stratifying the population based on their bio-specification for a tailored (personalized) therapy; and bed-side fast assessment of treatment efficacy in order to change the therapeutic approach. At the end, the letter pinpoints the main implementation strengths of the method as a routine diagnostic and monitoring in the digital era"
Keywords:		Breath Tests/methods Early Detection of Cancer/*methods Humans Lung Neoplasms/*diagnosis Mass Spectrometry/methods Volatile Organic Compounds/analysis Lung cancer biomarker breath sensor volatile organic compound;
Notes:		"MedlineHaick, Hossam Hashoul, Dina eng Editorial England 2019/05/03 Expert Rev Respir Med. 2019 Jul; 13(7):597-599. doi: 10.1080/17476348.2019.1614918. Epub 2019 May 8"